DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

11534019001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209799

On Market Since

7/4/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+0.2%

3M

-7.9%

6M

-1.6%

1Y

-10.7%

3Y

-16.9%

5Y

-25.0%

All

-27.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.